|  |  | 
 
  | All participants are invited to submit abstracts for oral or  poster presentation. Please see the themes for abstract submission and note the  important dates below.
 Important Dates
 Deadline of Abstract  Submission: Friday, February 28, 2014
 Notification of  Abstract Acceptance: Friday, March 7, 2014
 
 Themes
 
 
            Advancing Translational and Regenerative Medicine in Stem Cells Therapy 
Current  Clinical Applications of iPS Cell 
Nanotechnology and Medical Devices
 New Drug Discovery and Development
Patent Valuation and Patent Appraisals  Rules for SubmissionPlease note that abstracts should be submitted prior to Feb. 17, 2014. Abstracts without registration and payment will NOT be included  in the abstract book. Submission by letter, fax, e-mail or CD/DVD will NOT be  accepted at any time. Applicants must follow these guidelines:
 
            Abstract Submission Form: MS word for Windows.
Language: the abstract must be written in ENGLISH.
The abstract should be written in English, typed or printed in  Times New Roman font 12 and single space, with A4 size (21cm*29.7cm). Use  standard abbreviations and place a special or unusual abbreviation in  parenthesis after the full word appears. Use generic names of drugs. Write  numbers as numerals rather than words.
 Submit an abstract ONLY through Submission Online.
Please limit the length of your title to 15 words: Title should  be brief, clearly indicating the nature of the presentation. Use bold-faced and  capitalized font type for the title.
 Full name of all authors should be listed without degrees and  titles, and the presenting author should be underlined. Presenter's  organization should be included.
Tables, charts, photographs and any other information are not  acceptable as part of the abstract.
 The body of the abstract is limited to 250 words, excluding the  title and information on authors. (no more than one page)
The presenting author will be required to register before  submitting. (Payment is not required before the Announcement of Accepted Abstracts)    |  |